Literature DB >> 9495696

Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States.

R Orozco1, G O'Dowd, B Kunnel, M C Miller, R W Veltri.   

Abstract

OBJECTIVES: To evaluate pathology trends of 62,537 first-time prostate needle-core biopsies submitted by office-based urologists, processed at a single pathology laboratory.
METHODS: Prostate biopsy cases obtained over a 2-year period were assessed. Patient information included age, digital rectal examination (DRE) status, and prostate-specific antigen (PSA) serum levels. Biopsy pathology results included the number of tissue samples per case, Gleason score, presence of Gleason grades 4 or 5, percent of biopsy length with evidence of cancer, number of samples with cancer per biopsy, and determination of DNA ploidy status using microspectrophotometry.
RESULTS: Adenocarcinoma, suspicious lesions, and isolated high-grade prostatic intraepithelial neoplasia (PIN) were diagnosed in 38.3%, 2.9%, and 4.1% of the biopsies, respectively. For each serum PSA and age range assessed, the positive biopsy rate and incidence of critical pathologic features increased consistently. The average percentage of biopsy length with evidence of tumor, the percentage of cases with Gleason grades 4 or 5, and the percentage of cases with an abnormal DNA ploidy all decreased significantly over the 2-year period (P <0.01).
CONCLUSIONS: The number of tissue cores and anatomic sites (locations) being sampled per biopsy are increasing. The tumor size detected and percentage of cases with Gleason grades 4 and 5 are decreasing. There has been a slight increase in the number of biopsies performed on men younger than 60 years of age and a slight decrease in biopsies performed on men older than 70 years of age. The decline in meaningful pathologic features observed in biopsies over time may be clinically relevant to improved disease management.

Entities:  

Mesh:

Year:  1998        PMID: 9495696     DOI: 10.1016/s0090-4295(97)00620-1

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  10 in total

Review 1.  Biopsy standards for detection of prostate cancer.

Authors:  Bob Djavan; Markus Margreiter
Journal:  World J Urol       Date:  2007-03-07       Impact factor: 4.226

Review 2.  Strategies for repeat prostate biopsies.

Authors:  Martha K Terris
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

3.  The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients.

Authors:  Jeri Kim; Xifeng Wu; Yonggang He; Jian Gu; Sara Strom; Christopher J Logothetis
Journal:  Clin Cancer Res       Date:  2014-10-01       Impact factor: 12.531

4.  TRUS Biopsy Yield in Indian Population: A Retrospective Analysis.

Authors:  Sunil Raghunath Patil; Prakash Wamanrao Pawar; Ajit Somaji Sawant; Akshay Vijay Patil; Sayalee Suryabhan Narwade; Shankar Tanaji Mundhe; Abhishek Jaysukhbhai Savalia; Ashwin Sunil Tamhankar
Journal:  J Clin Diagn Res       Date:  2017-02-01

5.  Prostate gland biopsies and prostatectomies: an Ontario community hospital experience.

Authors:  Ken J Newell; John F Amrhein; Rashmikant J Desai; Paul F Middlebrook; Todd M Webster; Barry W Sawka; Brian F Rudrick
Journal:  Can Urol Assoc J       Date:  2008-10       Impact factor: 1.862

6.  Age-specific prostate specific antigen cutoffs for guiding biopsy decision in Chinese population.

Authors:  Rong Na; Yishuo Wu; Jianfeng Xu; Haowen Jiang; Qiang Ding
Journal:  PLoS One       Date:  2013-06-25       Impact factor: 3.240

7.  The additional value of TGFβ1 and IL-7 to predict the course of prostate cancer progression.

Authors:  Caroline Schroten; Natasja F Dits; Ewout W Steyerberg; Ries Kranse; Arno G J L H van Leenders; Chris H Bangma; Robert Kraaij
Journal:  Cancer Immunol Immunother       Date:  2011-11-24       Impact factor: 6.968

8.  Ten-core versus 16-core transrectal ultrasonography guided prostate biopsy for detection of prostatic carcinoma: a prospective comparative study in Indian population.

Authors:  V Surya Prakash; G Chandra Mohan; S Venkata Krishnaiah; V Vijaykumar; G Ramesh Babu; G Vijaya Bhaskar Reddy; V S Mahaboob
Journal:  Prostate Int       Date:  2013-12-30

9.  Accuracy of a high prostate-specific antigen level for prostate cancer diagnosis upon initial biopsy in Korean men.

Authors:  Hong Bang Shim; Sang Eun Lee; Hyoung Keun Park; Ja Hyeon Ku
Journal:  Yonsei Med J       Date:  2007-08-31       Impact factor: 2.759

Review 10.  Targeted prostate biopsy: value of multiparametric magnetic resonance imaging in detection of localized cancer.

Authors:  Jesse D Le; Jiaoti Huang; Leonard S Marks
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.